These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen. Bailón E, Ugarte-Berzal E, Amigo-Jiménez I, Van den Steen P, Opdenakker G, García-Marco JA, García-Pardo A. J Leukoc Biol; 2014 Aug; 96(2):185-99. PubMed ID: 25080557 [Abstract] [Full Text] [Related]
7. A novel CD44-binding peptide from the pro-matrix metalloproteinase-9 hemopexin domain impairs adhesion and migration of chronic lymphocytic leukemia (CLL) cells. Ugarte-Berzal E, Bailón E, Amigo-Jiménez I, Albar JP, García-Marco JA, García-Pardo A. J Biol Chem; 2014 May 30; 289(22):15340-9. PubMed ID: 24739387 [Abstract] [Full Text] [Related]
8. Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain. Redondo-Muñoz J, Ugarte-Berzal E, Terol MJ, Van den Steen PE, Hernández del Cerro M, Roderfeld M, Roeb E, Opdenakker G, García-Marco JA, García-Pardo A. Cancer Cell; 2010 Feb 17; 17(2):160-72. PubMed ID: 20159608 [Abstract] [Full Text] [Related]
9. Constitutive activation of the MAPkinase p38 is critical for MMP-9 production and survival of B-CLL cells on bone marrow stromal cells. Ringshausen I, Dechow T, Schneller F, Weick K, Oelsner M, Peschel C, Decker T. Leukemia; 2004 Dec 17; 18(12):1964-70. PubMed ID: 15483673 [Abstract] [Full Text] [Related]
10. Modifying akt signaling in B-cell chronic lymphocytic leukemia cells. Hofbauer SW, Piñón JD, Brachtl G, Haginger L, Wang W, Jöhrer K, Tinhofer I, Hartmann TN, Greil R. Cancer Res; 2010 Sep 15; 70(18):7336-44. PubMed ID: 20823161 [Abstract] [Full Text] [Related]
11. Matrix metalloproteinase-9 induces a pro-angiogenic profile in chronic lymphocytic leukemia cells. Aguilera-Montilla N, Bailón E, Ugarte-Berzal E, Uceda-Castro R, Prieto-Solano M, García-Martínez E, Samaniego R, Van den Steen PE, Opdenakker G, García-Marco JA, García-Pardo A. Biochem Biophys Res Commun; 2019 Nov 26; 520(1):198-204. PubMed ID: 31585732 [Abstract] [Full Text] [Related]
12. Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons. Bauvois B, Dumont J, Mathiot C, Kolb JP. Leukemia; 2002 May 26; 16(5):791-8. PubMed ID: 11986939 [Abstract] [Full Text] [Related]
13. Editorial: pro-matrix metalloproteinase-9 in tumor B lymphocytes: balancing migration and homing. Bauvois B. J Leukoc Biol; 2014 Aug 26; 96(2):164-6. PubMed ID: 25080556 [No Abstract] [Full Text] [Related]
14. Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis. Borst O, Schaub M, Walker B, Schmid E, Münzer P, Voelkl J, Alesutan I, Rodríguez JM, Vogel S, Schoenberger T, Metzger K, Rath D, Umbach A, Kuhl D, Müller II, Seizer P, Geisler T, Gawaz M, Lang F. Arterioscler Thromb Vasc Biol; 2015 Mar 26; 35(3):547-57. PubMed ID: 25614279 [Abstract] [Full Text] [Related]
17. Downregulation of microRNA-138 enhances the proliferation, migration and invasion of cholangiocarcinoma cells through the upregulation of RhoC/p-ERK/MMP-2/MMP-9. Wang Q, Tang H, Yin S, Dong C. Oncol Rep; 2013 May 26; 29(5):2046-52. PubMed ID: 23446431 [Abstract] [Full Text] [Related]
18. Gelatinase B/matrix metalloproteinase-9 contributes to cellular infiltration in a murine model of zymosan peritonitis. Kolaczkowska E, Chadzinska M, Scislowska-Czarnecka A, Plytycz B, Opdenakker G, Arnold B. Immunobiology; 2006 May 26; 211(3):137-48. PubMed ID: 16530081 [Abstract] [Full Text] [Related]